Susquehanna International Group’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Susquehanna International Group's MXCT Position: Q1 2026 in Review
Susquehanna International Group increased its MaxCyte (MXCT) stake by 122% in Q1 2026, buying an estimated $21.3K and bringing the position to 41,584 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12772.
Susquehanna International Group first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $791K in Q3 2022. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Susquehanna International Group held 41,584 shares of MaxCyte worth $29.2K as of Q1 2026.
- Susquehanna International Group bought 22,815 MaxCyte shares in Q1 2026, an estimated $21.3K.
- MaxCyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12772 holding.
- Susquehanna International Group first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
- Susquehanna International Group's MaxCyte position peaked at $791K in Q3 2022.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.